Skip to main content
. 2014 Aug 18;32(28):3111–3117. doi: 10.1200/JCO.2014.56.1068

Table 4.

Change in Age-Adjusted AUC for ER-Positive Breast Cancer

Risk Score Gail Score*
Rosner-Colditz Score
AUC SE Change in AUC SE P AUC SE Change in AUC SE P
Alone 54.4 1.9 59.1 2.0
Plus estrone 60.2 1.9 5.8 2.0 .005 62.3 2.0 3.2 1.8 .07
Plus estradiol 59.5 1.9 5.1 2.1 .01 61.2 2.0 2.1 1.7 .22
Plus estrone sulfate 60.8 1.9 6.4 2.2 .003 62.8 1.9 3.7 1.8 .04
Plus testosterone 58.5 1.9 4.2 2.0 .04 61.1 2.0 2.0 1.6 .20
Plus DHEAS 58.2 1.9 3.8 1.7 .03 61.1 2.0 2.0 1.4 .14
Plus SHBG 57.1 1.9 2.7 1.8 .13 60.1 2.0 1.0 1.4 .41
Plus prolactin 59.5 1.9 5.1 2.0 .01 62.0 2.0 2.9 1.7 .08
All hormones 63.5 1.8 9.1 2.3 < .001 65.1 1.9 6.0 2.0 .003
Estrone sulfate, SHBG, testosterone, and prolactin§ 63.2 1.8 8.8 2.3 < .001 64.9 1.9 5.8 2.0 .004
Using quartile categories for above four hormones 63.8 1.8 9.4 2.3 < .001 65.5 1.9 6.4 2.0 .002

NOTE. Adding endogenous hormone levels to Gail or Rosner-Colditz 5-year risk score.

Abbreviations: AUC, area under the curve; DHEAS, dehydroepiandrosterone sulfate; ER, estrogen receptor; SHBG, sex hormone–binding globulin.

*

Patient cases, n = 321.

Patient cases, n = 283.

P value indicates difference in AUC from model with only risk score.

§

Hormones selected via stepwise logistic regression; beta coefficients for best-subset hormones were 0.280 for estrone sulfate, 0.236 for testosterone, −0.197 for SHBG, and 0.336 for prolactin for Gail score and 0.256, 0.237, −0.150, and 0.370, respectively, for Rosner-Colditz score.